Device type · GWJ
Stimulator, Auditory, Evoked Response
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GWJ
Neurology
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
4
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Stimulator, Auditory, Evoked Response
- Product code
- GWJ
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1900
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for GWJ
Latest FDA decisions
K242954 · Decided Dec 19, 2024 · 85 days after receipt
Device type: Stimulator, Auditory, Evoked Response (GWJ) · Neurology & Neurosurgery
Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek)
K233649 · Decided Mar 8, 2024 · 115 days after receipt
Device type: Stimulator, Auditory, Evoked Response (GWJ) · Neurology & Neurosurgery
- QScreen510(k)
K220139 · Decided Aug 3, 2022 · 197 days after receipt
Device type: Stimulator, Auditory, Evoked Response (GWJ) · Neurology & Neurosurgery
5 more FDA decisions with a free account
Reports received
4
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
4
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 2 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Sparking4
- Electrical /Electronic Property Problem3
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MADSEN ACCUSCREEN TEOAE/DPOAE/ABR Probe (P/N 8-69-41100)Open, Classified
Z-0940-2026 · Started Nov 6, 2025 · Posted by FDA Dec 18, 2025
Reason given: Following a component change in the DPOAE probe (speaker replacement), technical distortions may occur at high stimulus levels combined with unusually low OAE amplitude acceptance thresholds. These distortions can mimic true DPOAE responses and may result in a false PASS outcome.
Cause as FDA categorized it: Component change control
- The ICS CHARTR EP 200Terminated
Z-0170-2020 · Started May 28, 2019
Reason given: There is a risk to the healthcare professional or patient of exposure to undergrounded electrical surfaces which may result in an electrical shock.
Cause as FDA categorized it: Device Design
- SonaMed Clarity System II; evoked response auditory stimulator; SonaMed Corp., Waltham, MA 02154Terminated
Z-2165-2010 · Started Jun 4, 2010 · Posted by FDA Aug 3, 2010
Reason given: There is insufficient evidence to support any claims for safety and efficacy on the SonaMed Clarity devices.
Cause as FDA categorized it: PMA
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.